Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
Epitalon (also rendered as Epithalon, Epithalone, or by the chemical descriptor AEDG) is a synthetic tetrapeptide that has attracted sustained interest in gerontology research. The compound was first synthesized at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson and colleagues, building on earlier work with epithalamin — a polypeptide extract isolated from bovine pineal gland tissue. Epitalon represents the short-sequence synthetic analog hypothesized to recapitulate the bioregulatory activity of the larger pineal extract.
Among the dozens of “short peptides” investigated by the Khavinson laboratory over a forty-year program, Epitalon has produced the most extensive published preclinical record. The body of work spans telomere biology, pineal/melatonin signaling, gene expression studies, and rodent lifespan models. Most of this research originates from a single Russian research group, though independent in vitro studies have begun to appear in the broader peer-reviewed literature.
This article reviews the published preclinical record on Epitalon research, the chemistry of the AEDG tetrapeptide, and the practical laboratory considerations relevant to in vitro and in vivo investigators.
Molecular Profile
Epitalon carries the amino acid sequence Ala-Glu-Asp-Gly (single-letter code: AEDG). It is one of the shortest bioactive peptides routinely investigated in aging research, with a molecular formula of C₁₄H₂₂N₄O₉ and a molecular weight of approximately 390.35 Da. The compound contains no cysteine residues and therefore does not form intramolecular disulfide bridges; it is also free of post-translational modifications.
For laboratory use, Epitalon is typically supplied as a lyophilized white powder. The peptide is highly water-soluble and is reconstituted in sterile bacteriostatic water or 0.9% saline for in vitro and in vivo work. Its small size and absence of glycosylation contribute to a straightforward synthesis profile, and high-purity material is routinely achievable via solid-phase peptide synthesis.
Mechanism of Action
The proposed mechanisms underlying Epitalon’s observed effects remain an active area of investigation. Three broad lines of inquiry have produced the most data: telomerase modulation, pineal/melatonin signaling, and direct interaction with chromatin.
Khavinson and colleagues (2003) reported in Bulletin of Experimental Biology and Medicine that Epitalon treatment was associated with induction of telomerase activity and elongation of telomeres in cultured human somatic cells. The proposed framework involves transcriptional upregulation of TERT (the catalytic subunit of telomerase) following peptide exposure. Subsequent in vitro work has continued to examine this hypothesis using updated assay methodologies.
A second mechanistic framework, developed by Anisimov and colleagues, focuses on the peptide’s apparent ability to influence pineal function and circadian melatonin output in aged rodent models. The hypothesis posits that AEDG modulates expression of genes involved in pineal indoleamine metabolism, restoring melatonin rhythm parameters that decline with chronological age in laboratory animals.
A third line of inquiry, advanced more recently, frames Epitalon as a “peptide regulator of gene expression” capable of direct DNA interaction. Computational and in vitro work has examined whether short peptides such as AEDG can bind specific sequences in promoter regions and modulate transcription. This proposal remains contested and is the subject of ongoing methodological debate.
Key Research Areas
1. Telomere and Telomerase Research
The telomere/telomerase work is the most widely cited domain of Epitalon research. Khavinson V.Kh., Bondarev I.E., Butyugov A.A. published a foundational study in Bulletin of Experimental Biology and Medicine (2003) reporting that Epitalon treatment of cultured human somatic cells (fibroblasts) increased telomerase activity and produced measurable telomere elongation (PMID: 12937682). The authors framed the finding as evidence that exogenous short peptides could influence replicative senescence parameters in vitro. The proposed mechanistic framework involves transcriptional upregulation of TERT (the catalytic subunit of telomerase) following peptide exposure, though the molecular pathway connecting AEDG exposure to TERT transcription has not been definitively established.
A more recent independent study published in Biogerontology (2025) by international investigators revisited the question using contemporary telomere measurement methodology, reporting that Epitalon treatment increased telomere length in selected human cell lines through what the authors describe as either telomerase upregulation or alternative lengthening of telomeres (ALT) activity, depending on the cellular context. The paper represents one of the first independent replications outside the original Khavinson program and contributes to ongoing methodological discussion in the field. The methodological discussion centers on assay choice: TRAP (telomere repeat amplification protocol), qPCR-based telomere length measurement, and Q-FISH each have different sensitivity profiles and susceptibility to assay artifact, and apparent positive findings in one assay system may not reproduce in another.
2. Pineal Gland and Melatonin Research
A substantial body of Russian-language and English-translated work has examined Epitalon in the context of pineal physiology and circadian biology. Anisimov V.N. and Khavinson V.Kh. published a review in Biogerontology (2010) summarizing rodent studies in which Epitalon administration was associated with normalization of melatonin output rhythm parameters in aged animals and with effects on circadian gene expression markers in pineal tissue (PMID: 19543815). These investigations form the basis for the peptide’s classification within the “pineal peptide” research category. The proposed connection between AEDG and pineal indoleamine metabolism remains hypothesis-generating; the molecular mechanism by which a four-amino-acid peptide would specifically modulate pineal gene expression has not been worked out at the level of detail required for independent mechanistic verification.
Korkushko et al. (2011), publishing in Bulletin of Experimental Biology and Medicine, reported on a 15-year follow-up of peptide-treated elderly cohorts, presenting outcome data that the authors framed as supporting a geroprotective effect (PMID: 22451889). The work has been cited in the broader Khavinson-school literature but, like much of the original group’s output, has had limited independent replication in non-Russian research settings, leaving questions about generalizability across populations and laboratory contexts.
3. Longevity and Aging Models
Preclinical lifespan studies in rodents have been a defining feature of the Epitalon literature. Anisimov V.N., Khavinson V.Kh., Provinciali M., et al. conducted multi-year studies in mice reporting effects of chronic peptide administration on parameters including mean lifespan, tumor incidence, and several biomarkers of aging. The 2002 paper in International Journal of Cancer reported an inhibitory effect of Epitalon on spontaneous mammary tumor development in HER-2/neu transgenic mice (PMID: 12209581). The findings have been published in journals including Mechanisms of Ageing and Development and Experimental Gerontology, and have been the subject of subsequent meta-analytic discussion. Investigators reviewing this body of work note both its breadth and the methodological limitations of single-laboratory provenance — most of the rodent lifespan data trace to the Khavinson and Anisimov programs, and independent replication of multi-year lifespan endpoints by other laboratories has been limited.
4. Gene Expression and Epigenetic Research
Work in the late 2010s and into the 2020s has examined whether Epitalon and related short peptides influence gene expression patterns in cultured cells. Khavinson V.Kh., Lin’kova N.S., Tarnovskaya S.I. published in Bulletin of Experimental Biology and Medicine (2020) reporting that AEDG peptide stimulates gene expression and protein synthesis during neurogenesis in cultured cells, with the authors proposing an epigenetic mechanism (PMID: 32019204). These investigations remain preclinical and the proposed mechanism has not been independently confirmed across all assay systems. The Khavinson et al. (2021) systematic review in Molecules summarized the broader case for peptide regulation of gene expression, framing AEDG and related short peptides as candidate transcriptional modulators with proposed sequence-specific DNA-binding activity (PMID: 34834151). The DNA-binding hypothesis remains contested in the broader biochemistry literature, with critics noting the limited biophysical evidence for sequence-specific binding by four-residue peptides and the methodological challenges of detecting low-affinity, transient nuclear interactions.
For investigators exploring related longevity-associated research peptides, mitochondrial-derived compounds such as MOTS-c represent a complementary area of preclinical inquiry, while NAD precursors are widely studied in aging contexts. Within the broader “short peptide” research category developed by the Khavinson school, related compounds (Pinealon, Vesugen, Vilon, and others) have been investigated with similar methodological approaches and similar limitations regarding independent replication.
Comparative Research Landscape
Epitalon sits within a distinctive research lineage — the Khavinson-school “short peptide” program — that has produced a substantial body of work over four decades but has had limited integration into the broader Western academic gerontology literature. Within this lineage, AEDG is paired conceptually with epithalamin (the bovine pineal extract from which Epitalon was rationally derived as a short synthetic analog) and with other short peptides characterized by the same group: Pinealon (Glu-Asp-Arg), Vesugen (Lys-Glu-Asp), Vilon (Lys-Glu), and a series of additional sequences. Comparisons across the Khavinson short peptide family typically center on tissue specificity (proposed pineal specificity for Epitalon, vascular for Vesugen, neural for Pinealon) rather than on mechanistic distinction.
Compared with the broader gerontology research toolkit, Epitalon occupies a distinct niche. Most contemporary aging research focuses on small-molecule senolytics (dasatinib, quercetin, fisetin), mTOR inhibitors (rapamycin and analogs), NAD+ precursors (nicotinamide riboside, nicotinamide mononucleoside), and other pathway-targeted approaches with well-characterized mechanism. Epitalon’s proposed mechanisms — telomerase modulation, pineal modulation, gene expression regulation — overlap conceptually with these areas but rest on a different (and less independently replicated) evidence base. Investigators selecting Epitalon as a research tool typically do so to engage with the Khavinson short peptide hypothesis specifically, not as a substitute for better-characterized pathway-targeted approaches.
Within the telomere biology toolkit, Epitalon is positioned alongside small-molecule telomerase activators (TA-65 and related cycloastragenol derivatives) and direct telomerase enzyme/expression manipulation strategies (TERT overexpression, gene therapy approaches). The relative selectivity, potency, and reproducibility of these approaches across laboratories differ substantially, and any cross-comparison should explicitly acknowledge the methodological heterogeneity of the published evidence base.
Research Methodology Considerations
Methodologically, Epitalon research faces challenges that span peptide pharmacology, telomere biology, and the broader interpretive complexity of single-laboratory evidence bases. Investigators designing rigorous Epitalon studies should consider the following.
Assay choice for telomere endpoints. Telomere length and telomerase activity measurements are technically demanding. TRAP assays measure telomerase enzymatic activity but can be confounded by PCR amplification artifacts and require careful internal-control standardization. qPCR-based telomere length measurement (T/S ratio) is throughput-friendly but has limited single-cell resolution. Q-FISH provides chromosome-level resolution but requires specialized expertise. Investigators should report which assay was used and ideally validate findings across multiple methods.
Cell-line selection. Reported Epitalon effects on telomere parameters have been observed in selected human cell lines but have not been universally reproducible across cell systems. The choice of cell line — primary fibroblasts versus cancer-derived immortalized lines versus stem cell lines — substantially shapes the available telomerase machinery and the responsiveness of telomere length to exogenous interventions. Investigators should report cell-line provenance, passage number, and baseline telomerase activity.
In vivo dose-ranging. Published Epitalon rodent protocols use a wide range of doses (typically µg/kg to low mg/kg ranges), administration routes (subcutaneous and intraperitoneal predominantly), and dosing schedules (daily, intermittent, course-based). Standardization across the published protocols is limited, and investigators conducting new studies should explicitly justify dose selection rather than uncritically following any single published protocol.
Control arm design. Vehicle controls and, where appropriate, scrambled-sequence peptide controls are appropriate for distinguishing sequence-specific from non-specific effects. The use of scrambled-sequence controls is particularly important for small peptides where any biological effect could plausibly trace to amino acid content rather than sequence-specific interactions.
Statistical and methodological reporting. Given the historical concentration of Epitalon evidence within one research lineage, transparent statistical and methodological reporting — pre-registration where possible, complete primary data availability, and explicit power analysis — is particularly important for advancing the field beyond its current state.
Research Considerations for Laboratory Use
For investigators working with Epitalon in laboratory settings, the compound’s small size and high aqueous solubility simplify several aspects of handling. Lyophilized material should be stored at −20°C or below prior to reconstitution. Reconstituted solutions are typically prepared in sterile bacteriostatic water or 0.9% saline, and should be used promptly or stored short-term at 2–8°C in line with stability data for the specific preparation.
Research-grade Epitalon is typically characterized at ≥98% purity by HPLC analysis, with identity confirmed by mass spectrometry (expected molecular weight: 390.35 Da). Reputable suppliers provide lot-specific certificates of analysis (CoAs) documenting purity, water content, residual solvents, and sterility. These documents are an essential part of any reproducible research protocol using synthetic peptides.
Conclusion
Epitalon occupies a distinctive position in the peptide research landscape: a small, well-characterized tetrapeptide with a long Russian publication history, a developing body of independent replication work, and several mechanistic hypotheses still under active investigation. The telomere and pineal research domains remain the most heavily cited, while questions about epigenetic action and gene-level effects continue to attract methodological discussion.
As with any compound at this stage of investigation, conclusions about mechanism, efficacy, and safety in human systems remain premature. Investigators interested in Epitalon as a laboratory tool should engage with the primary literature critically — including the original Khavinson-laboratory publications and the emerging independent work — and design experiments with appropriate controls and validated end points.
Frequently Asked Questions
What is Epitalon?
Epitalon (also spelled Epithalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It was developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology as a short synthetic analog of epithalamin, a peptide preparation derived from bovine pineal tissue. It is produced for research purposes only and is not approved for human or veterinary use.
What research has been conducted on Epitalon?
The majority of published Epitalon research consists of preclinical investigations in cell culture and rodent models. Key research areas include telomerase activity and telomere length measurements in human cell lines, pineal/melatonin rhythm studies in aged rodents, multi-year lifespan and tumor-incidence studies in mice, and gene expression studies in neurogenesis models. Independent replication outside the original Khavinson program is limited but emerging.
How is Epitalon used in research settings?
In published preclinical studies, Epitalon has been administered via subcutaneous and intraperitoneal injection in rodent models, and added directly to cell culture media for in vitro work. Dose ranges and dosing schedules vary considerably across published protocols. Researchers working with the compound should consult primary literature for model-specific parameters and obtain material with verified identity and purity documentation.
What is the purity standard for research-grade Epitalon?
Research-grade Epitalon is typically characterized at ≥98% purity by HPLC analysis, with identity confirmed by mass spectrometry (expected molecular weight: 390.35 Da). Reputable suppliers provide lot-specific certificates of analysis (CoAs) documenting purity, water content, residual solvents, and sterility. These documents support reproducibility in any research protocol using synthetic peptides.
How does Epitalon differ from the related compound epithalamin?
Epithalamin is a polypeptide preparation extracted from bovine pineal tissue and contains a mixture of peptide species. Epitalon (AEDG) is a defined synthetic tetrapeptide that was rationally derived as a short synthetic analog of epithalamin. The synthetic compound offers chemical definition, lot-to-lot consistency, and ease of analytical characterization that the natural extract cannot provide. Whether the four-residue peptide fully recapitulates the bioactivity of the larger natural extract is an open question.
What is the role of TERT in proposed Epitalon mechanisms?
TERT (telomerase reverse transcriptase) is the catalytic subunit of the telomerase enzyme complex. Proposed Epitalon mechanisms include transcriptional upregulation of TERT, which would in principle increase telomerase activity and support telomere length maintenance or elongation. The molecular pathway connecting AEDG exposure to TERT transcription has not been established at the level of detail required for independent mechanistic verification.
Why is independent replication a recurring theme in Epitalon discussion?
Most published Epitalon research traces to a single laboratory program (Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology) over a roughly four-decade period. Single-laboratory provenance is a recognized limitation in evidence-base evaluation, motivating particular interest in independent replication. A 2025 Biogerontology paper represents one of the first independent in vitro replications and contributes to ongoing methodological discussion. Additional independent work across multiple laboratories would strengthen the field’s interpretation of the existing literature.
How is Epitalon typically administered in rodent research?
Subcutaneous and intraperitoneal injection are the most commonly published routes. Doses range across published protocols from µg/kg to low mg/kg, with schedules ranging from daily to intermittent to defined-course administration. Standardization across the published protocols is limited, and investigators planning new studies should consult primary literature for model-specific parameters and explicitly justify dose selection.
What are the most common analytical concerns with Epitalon?
Epitalon is chemically simple — four standard amino acids, no disulfides, no glycosylation, no modified residues — and is readily synthesized by solid-phase peptide synthesis. Standard concerns include purity (≥98% by HPLC), identity confirmation by mass spectrometry (390.35 Da), water content, residual solvent levels, and absence of deletion sequences from synthesis errors. The compound is highly water-soluble and chemically stable, simplifying handling compared with longer or more complex peptides.
References
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;135(6):590–592. PMID: 12937682.
- Khavinson VKh, Lin’kova NS, Tarnovskaya SI. AEDG peptide (Epitalon) stimulates gene expression and protein synthesis during neurogenesis: possible epigenetic mechanism. Bulletin of Experimental Biology and Medicine. 2020;168(3):394–397. PMID: 32019204.
- Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139–149. PMID: 19543815.
- Anisimov VN, Khavinson VKh, Provinciali M, et al. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer. 2002;101(1):7–10. PMID: 12209581.
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters. 2003;24(3–4):233–240. PMID: 14523363.
- Korkushko OV, Khavinson VKh, Shatilo VB, Antonyk-Sheglova IA. Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-up. Bulletin of Experimental Biology and Medicine. 2011;151(3):366–369. PMID: 22451889.
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide regulation of gene expression: a systematic review. Molecules. 2021;26(22):7053. PMID: 34834151.
- Khavinson VKh, Linkova NS, Polyakova VO, Kheifets OV, Tarnovskaya SI, Kvetnoy IM. Peptides tissue-specifically stimulate cell differentiation during their aging. Bull Exp Biol Med. 2012;153(1):148–151. PMID: 22808511.
- Anisimov VN, Khavinson VKh, Mikhalski AI, Yashin AI. Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice. Mech Ageing Dev. 2001;122(1):41–68. PMID: 11163623.
- Kossoy G, Anisimov VN, Khavinson VKh, et al. Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice. In Vivo. 2006;20(2):253–257. PMID: 16634526.
Epitalon is supplied for in vitro and in vivo laboratory research use only. It is not approved for human or veterinary use.
